Engku Nur Syafirah Engku Abd Rahman (Engku Nur Syafirah E A R)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Long Noncoding Rna

Systematic Review

Hodgkin Lymphoma

Top Venues

Antibiotics (Basel, Switzerland)

Diagnostics (Basel, Switzerland)

Medicina (Kaunas, Lithuania)

Universiti Sains Malaysia Pusat Pengajian Sains Perubatan (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Universiti Sains Malaysia Pusat Pengajian Sains Perubatan Mar 01 2014 - Oct 28 2017

Malaysia

MSC :: Medical Microbiology and Parasitology

Universiti Sains Malaysia Pusat Pengajian Sains Perubatan Jun 01 2008 - Sep 29 2012

Malaysia

BSC :: Medical Microbiology and Parasitology

Publications

Nurul Izzaty Najwa Zahari, Engku Nur Syafirah Engku Abd Rahman, Ahmad Adebayo Irekeola, Naveed Ahmed, Ali A Rabaan, Jawaher M Al-Otaibi, Shayea A Alqahtani, Mohammed Y Halawi, Ibrahim Ateeq Alamri, Mohammed Suliman Almogbel, Amal H Alfaraj, Fatimah Al Ibrahim, Manar Almaghaslah, Mohammed Alissa, Chan Yean Yean
A Review of the Resistance Mechanisms for β -Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae . Medicina (Kaunas, Lithuania) 59 (11) (2023)
Yusuf Wada, Ahmad Adebayo Irekeola, Engku Nur Syafirah Engku Abd Rahman, Wardah Yusof, Lee Lih Huey, Suwaiba Ladan Muhammad, Azian Harun, Chan Yean Yean, Abdul Rahman Zaidah
Prevalence of Vancomycin-Resistant Enterococcus (VRE) in Companion Animals: The First Meta-Analysis and Systematic Review. Antibiotics (Basel, Switzerland) 10 (2) (2021)
Engku Nur Syafirah Engku Abd Rahman, Ahmad Adebayo Irekeola, Chan Yean Yean
Diagnostic and Prognostic Indications of Nasopharyngeal Carcinoma. Diagnostics (Basel, Switzerland) 10 (9) (2020)
Mohammad A I Al-Hatamleh, Engku Nur Syafirah Engku Abd Rahman, Jennifer C Boer, Emmanuel Ibarboure, Jean-Luc Six, Xin Chen, Eyad Elkord, Magdalena Plebanski, Rohimah Mohamud
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment. Cells 9 (1) (2019)